Omega Fund Management as of Dec. 31, 2017
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | 33.6 | $47M | 2.6M | 17.90 | |
| Juno Therapeutics | 24.9 | $34M | 754k | 45.71 | |
| Sienna Biopharmaceuticals (SNNAQ) | 9.9 | $14M | 759k | 18.15 | |
| Obseva Sa | 7.1 | $9.8M | 1.0M | 9.76 | |
| Jounce Therapeutics | 5.3 | $7.4M | 580k | 12.75 | |
| Pieris Pharmaceuticals (PIRS) | 4.9 | $6.8M | 904k | 7.55 | |
| Fibrogen (FGEN) | 4.5 | $6.2M | 131k | 47.40 | |
| Cymabay Therapeutics | 3.7 | $5.1M | 552k | 9.20 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 2.2 | $3.0M | 445k | 6.80 | |
| Egalet | 2.1 | $2.9M | 2.9M | 1.00 | |
| Dicerna Pharmaceuticals | 1.5 | $2.0M | 224k | 9.03 | |
| Essa Pharma | 0.3 | $373k | 1.7M | 0.22 |
